COMMENT

Market. We are in a Twilight Zone right now – we have seen the best of the market and from here on in we are in a trading market. Investors will not buy something and hold it for five years anymore. Strange things will happen – like Bitcoin – things that happen near the end of the cycle. The Nasdaq still has rooms to fall – one nasty day does not a correction make. He thinks a pullback to 2550 for the S&P is likely.

COMMENT

Gold. In two years the Trump Administration will not want to have a bad economy going into the election. The FED Reserve will continue to create inflationary pressure, which will be good for gold.

HOLD

This stock is very close to its usual long term low. This utility tends to bottom as the market is topping. He does not think it has stopped falling yet and thinks it has another 8-10% downside yet to go. He would suggest holding if you already have it.

DON'T BUY

The company reached a big target at 10 times book value near $120. The problem is that its intrinsic value, based on earnings growth, is about 30% lower than the current stock price. It the market has a pullback, this could pull back to at least $93.

HOLD

A managed care provider in the US. He thinks the stock still have 22% upside and the earnings are rising. The bad news is it is trading at 2.5 times book value, when a few years ago it traded at book value. He likes the sector and in the long term this should be fine.

BUY ON WEAKNESS

In light of Stronach suing his daughter, this is an interesting stock. Recently they reached 2 times book value – an extended valuation given how late we are in the business cycle. If the stock dropped another $6 it would be back to fair value.

STRONG BUY

He sees it at $4.50 earnings per share – trading at 27 times earnings. It has traded back to $156, his target, and would see it as a buy. (Analysts’ price target is $220)

DON'T BUY

If they sell some assets, it would help the balance sheet, he thinks. The company is paying out almost twice what it is earning. The results in the balance sheet melting away. They would do an enormous service to cut the dividend to a sustainable yield, like 5%.

BUY

The dividend is definitely sustainable. They are paying out less than half their earnings. They had some mortgage issues in the past, but the stock price is at a very attractive level. Yield 6.3%.

WATCH

Lumber stocks and home builders in the US have a stock chart like this one – plunging down to the right. At these levels, the valuations are suggesting a depression is coming – he does not believe in this. His downside target is $66, so based on his model, it is a buy if the market can find a bottom soon.

HOLD

Uranium stocks are cheap on a price to book basis, he thinks. The issue now is when will new long term contracts come in? When will the Japanese come back? Nor are we hearing of any rumours of new contracts. It is hard to see a positive outlook. He would continue to hold.

DON'T BUY

He thinks the valuation is in excess of its intrinsic value. He would look at it at $108 and even then feels it might be a gamble. If interest rates are looking to rise, this could create headwinds. He sees $140 as being critical support.

DON'T BUY

The company has a hydroponic division that is getting into cannabis. He thinks cannabis is a busy space with 168 companies now claiming activity in the field. His analysis suggests (based on Colorado’s experience) the sector will face rapidly plateauing sales after the first couple of years. About 6% of the population turned out to be regular users and 80% of the population doesn’t care. He would not buy this based on their entry into cannabis.

BUY ON WEAKNESS

It has a good possibility of pulling back to $67, where it would be a spectacular buying opportunity.

BUY

It has come off some still technical resistance, but sees it trading at cheap values. (Analysts’ price target is $35)